TAK
Price
$12.92
Change
-$0.13 (-1.00%)
Updated
Jan 17 closing price
Capitalization
43.11B
12 days until earnings call
TKPHF
Price
$24.35
Change
+$0.10 (+0.41%)
Updated
Jan 16 closing price
Capitalization
47.94B
Ad is loading...

TAK vs TKPHF

Header iconTAK vs TKPHF Comparison
Open Charts TAK vs TKPHFBanner chart's image
Takeda Pharmaceutical
Price$12.92
Change-$0.13 (-1.00%)
Volume$1.4M
Capitalization43.11B
Takeda Pharmaceutical
Price$24.35
Change+$0.10 (+0.41%)
Volume$686
Capitalization47.94B
TAK vs TKPHF Comparison Chart
Loading...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TKPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TAK vs. TKPHF commentary
Jan 19, 2025

To understand the difference between Takeda Pharmaceutical Co - ADR (TAK) vs. Takeda Pharmaceutical Co (TKPHF) it is enough to know the definitions of ADR

ADR - American depositary receipt (ADR) is a certificate issued by a U.S. depositary bank representing a specified number of shares (often 1 share) of a foreign company's stock. ADRs are denominated in U.S. dollars and trade on U.S. stock markets and OTC depending on the ADRs classification.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (TAK: $12.92 vs. TKPHF: $24.35)
Brand notoriety: TAK and TKPHF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: TAK: 75% vs. TKPHF: 4%
Market capitalization -- TAK: $43.11B vs. TKPHF: $47.94B
TAK [@Pharmaceuticals: Other] is valued at $43.11B. TKPHF’s [@Pharmaceuticals: Other] market capitalization is $47.94B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TAK’s FA Score shows that 1 FA rating(s) are green whileTKPHF’s FA Score has 1 green FA rating(s).

  • TAK’s FA Score: 1 green, 4 red.
  • TKPHF’s FA Score: 1 green, 4 red.
According to our system of comparison, both TAK and TKPHF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TAK’s TA Score shows that 4 TA indicator(s) are bullish while TKPHF’s TA Score has 4 bullish TA indicator(s).

  • TAK’s TA Score: 4 bullish, 1 bearish.
  • TKPHF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, TAK is a better buy in the short-term than TKPHF.

Price Growth

TAK (@Pharmaceuticals: Other) experienced а -0.23% price change this week, while TKPHF (@Pharmaceuticals: Other) price change was -6.95% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.30%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was -9.85%.

Reported Earning Dates

TAK is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.30% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TKPHF($47.9B) has a higher market cap than TAK($43.1B). TAK has higher P/E ratio than TKPHF: TAK (36.79) vs TKPHF (22.47). TAK YTD gains are higher at: -2.417 vs. TKPHF (-8.972). TKPHF has higher annual earnings (EBITDA): 1.15T vs. TAK (1.01T). TKPHF has more cash in the bank: 369B vs. TAK (317B). TAK (4.66T) and TKPHF (4.75T) have identical debt. TAK (4.17T) and TKPHF (4.11T) have equivalent revenues.
TAKTKPHFTAK / TKPHF
Capitalization43.1B47.9B90%
EBITDA1.01T1.15T88%
Gain YTD-2.417-8.97227%
P/E Ratio36.7922.47164%
Revenue4.17T4.11T101%
Total Cash317B369B86%
Total Debt4.66T4.75T98%
FUNDAMENTALS RATINGS
TAK vs TKPHF: Fundamental Ratings
TAK
TKPHF
OUTLOOK RATING
1..100
1379
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8383
PRICE GROWTH RATING
1..100
7379
P/E GROWTH RATING
1..100
9394
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TKPHF's Valuation (4) in the null industry is in the same range as TAK (5) in the Pharmaceuticals Major industry. This means that TKPHF’s stock grew similarly to TAK’s over the last 12 months.

TKPHF's Profit vs Risk Rating (100) in the null industry is in the same range as TAK (100) in the Pharmaceuticals Major industry. This means that TKPHF’s stock grew similarly to TAK’s over the last 12 months.

TKPHF's SMR Rating (83) in the null industry is in the same range as TAK (83) in the Pharmaceuticals Major industry. This means that TKPHF’s stock grew similarly to TAK’s over the last 12 months.

TAK's Price Growth Rating (73) in the Pharmaceuticals Major industry is in the same range as TKPHF (79) in the null industry. This means that TAK’s stock grew similarly to TKPHF’s over the last 12 months.

TAK's P/E Growth Rating (93) in the Pharmaceuticals Major industry is in the same range as TKPHF (94) in the null industry. This means that TAK’s stock grew similarly to TKPHF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TAKTKPHF
RSI
ODDS (%)
Bullish Trend 11 days ago
44%
N/A
Stochastic
ODDS (%)
Bearish Trend 11 days ago
56%
Bearish Trend 11 days ago
51%
Momentum
ODDS (%)
Bullish Trend 11 days ago
38%
Bullish Trend 11 days ago
47%
MACD
ODDS (%)
Bullish Trend 11 days ago
34%
Bullish Trend 11 days ago
46%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
43%
Bullish Trend 11 days ago
47%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
44%
Bullish Trend 11 days ago
44%
Advances
ODDS (%)
Bullish Trend 12 days ago
43%
Bullish Trend 19 days ago
43%
Declines
ODDS (%)
Bearish Trend about 1 month ago
45%
Bearish Trend about 1 month ago
48%
BollingerBands
ODDS (%)
N/A
Bearish Trend 11 days ago
53%
Aroon
ODDS (%)
N/A
Bearish Trend 11 days ago
49%
View a ticker or compare two or three
Ad is loading...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TKPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GOOY15.240.14
+0.93%
YieldMax GOOGL Option Income Stgy ETF
PVAL38.330.20
+0.52%
Putnam Focused Large Cap Value ETF
MNBD25.530.05
+0.20%
ALPS Intermediate Municipal Bond ETF
PHB18.220.02
+0.11%
Invesco Fundamental Hi Yld® Corp Bd ETF
DYLG26.43N/A
N/A
Global X Dow 30 Covered Call & GrowthETF

TAK and

Correlation & Price change

A.I.dvisor indicates that over the last year, TAK has been loosely correlated with SGIOY. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TAK jumps, then SGIOY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAK
1D Price
Change %
TAK100%
-1.00%
SGIOY - TAK
41%
Loosely correlated
+1.42%
ESAIY - TAK
35%
Loosely correlated
+1.96%
BNXTF - TAK
32%
Poorly correlated
N/A
TKPHF - TAK
27%
Poorly correlated
N/A
ELAN - TAK
27%
Poorly correlated
+0.08%
More

TKPHF and

Correlation & Price change

A.I.dvisor tells us that TKPHF and TAK have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TKPHF and TAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TKPHF
1D Price
Change %
TKPHF100%
N/A
TAK - TKPHF
27%
Poorly correlated
-1.00%
TEVJF - TKPHF
17%
Poorly correlated
N/A
ZTS - TKPHF
16%
Poorly correlated
-2.05%
BHC - TKPHF
15%
Poorly correlated
-2.75%
QNTM - TKPHF
13%
Poorly correlated
+3.32%
More